A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-α inhibitor

A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-α inhibitor

Journal of Pharmacology and Experimental Therapeutics

Saved in:

Bibliographic Details
Main Authors:	Yang, X.-X., Hu, Z.-P., Chan, E., Zhou, S.-F., Sheu, F.-S., Duan, W., Zhu, Y.-Z., Bian, J.-S., Xu, A.-L., Huang, M., Zhang, Q., Wang, J.-C., Li, X.
Other Authors:	BIOCHEMISTRY
Format:	Article
Published:	2011
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/28788
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-α inhibitor
by: Yang, X.-X., et al.
Published: (2014)

Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
by: Yang, X.-X., et al.
Published: (2011)

Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
by: Yang, X.-X., et al.
Published: (2011)

Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
by: Yang, X.-X., et al.
Published: (2014)

A mechanistic study on altered pharmacokinetics of irinotecan by St. John's Wort
by: Hu, Z.-P., et al.
Published: (2014)

St. John's wort modulates the toxicities and pharmacokinetics of CPT-11 (Irinotecan) in rats
by: Hu, Z., et al.
Published: (2014)

The Inhibitory effect of thalidomide on the production of tumor necrosis factor alpha : a study in tuberculosis patients / Utaiwan Utaipat
by: Utaiwan Utaipat
Published: (2014)

Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
by: Shi, R.-X., et al.
Published: (2014)

Chrysin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB
by: Li, X., et al.
Published: (2011)

Water-soluble polysaccharides of Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (Aphyllophoromycetideae) alleviate the dose-limiting toxicities of irinotecan (CPT-11)
by: Hu, Z., et al.
Published: (2014)

Thalidomide revisited
by: Shek, L.P.C.
Published: (2016)

Novel agents that potentially inhibit irinotecan-induced diarrhea
by: Yang, X., et al.
Published: (2012)

Novel agents that potentially inhibit irinotecan-induced diarrhea
by: Yang, X., et al.
Published: (2014)

Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort
by: YANG XIAOXIA
Published: (2010)

Thalidomide in Behçet's disease
by: Shek, L.P.C., et al.
Published: (2014)

Determination of thalidomide by high performance liquid chromatography: Plasma pharmacokinetic studies in the rat
by: Yang, X., et al.
Published: (2011)

Determination of thalidomide by high performance liquid chromatography: Plasma pharmacokinetic studies in the rat
by: Yang, X., et al.
Published: (2014)

Novel synthetic luteolin analogue-caused sensitization of tumor necrosis factor-α-induced apoptosis in human tumor cells
by: Cheng, L., et al.
Published: (2014)

Novel synthetic luteolin analogue-caused sensitization of tumor necrosis factor-α-induced apoptosis in human tumor cells
by: Cheng, L., et al.
Published: (2011)

Identification of a new receptor subtype for tumor necrosis factor-α
by: Schwalb, D.M., et al.
Published: (2014)

Tumor necrosis factor-α gene promoter polymorphisms in chronic schizophrenia
by: Tan, E.-C., et al.
Published: (2014)

Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
by: Lee L.S.-U., et al.
Published: (2018)

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1
by: Wang, L, et al.
Published: (2020)

Strong association of a tumor necrosis factor-α promoter allele with cerebral malaria in Myanmar
by: R. Ubalee, et al.
Published: (2018)

Thalidomide responsiveness in an infant with Behcet's syndrome
by: Lee, B.W., et al.
Published: (2012)

Polyclonal anti-tumor necrosis factor-α Fab used as an ancillary treatment for severe malaria
by: S. Looareesuwan, et al.
Published: (2018)

Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: Application to cellular metabolism and accumulation studies
by: Hu, Z.-P., et al.
Published: (2014)

Tumor necrosis factor-α polymorphism, bone strength phenotypes, and the risk of fracture in older women
by: Moffett, S.P, et al.
Published: (2020)

Dendritic cell-derived interferon-γ-induced protein mediates tumor necrosis factor-α stimulation of human lung fibroblasts
by: Liao, W., et al.
Published: (2014)

Dendritic cell-derived interferon-γ-induced protein mediates tumor necrosis factor-α stimulation of human lung fibroblasts
by: Liao, W., et al.
Published: (2011)

Role of tumor necrosis factor-α in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate
by: Liew, R., et al.
Published: (2016)

C-reactive protein, interleukin-6, and tumor necrosis factor-α levels in overweight and healthy adults
by: S. Chaikate, et al.
Published: (2018)

St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis
by: Hu, Z.-P., et al.
Published: (2011)

St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis
by: Hu, Z.-P., et al.
Published: (2014)

Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
by: Shaikh, I.M., et al.
Published: (2014)

DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012)

Tumor necrosis factor-α gene promoter polymorphism is not associated with smoking-related COPD in Thailand
by: Nitipatana Chierakul, et al.
Published: (2018)

Transport of thalidomide by the human intestinal Caco-2 monolayers
by: Zhou, S., et al.
Published: (2014)

Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c- Myc-dependent apoptosis
by: Jänicke, R.U., et al.
Published: (2014)

Tumor necrosis factor in septicemic melioidosis
by: Y. Suputtamongkol, et al.
Published: (2018)